News | July 26, 2023
Syngene Q1 FY 2024 revenue up 26% to Rs. 832 crores, PAT up 26% to Rs.93 Cr
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24
CARA is a data and content management platform that helps companies in regulated industries such as finance, energy, and manufacturing transform their complex business processes
Tiotropium (as bromide monohydrate) 18 micrograms powder for inhalation in capsule
The approval allows treatment of heart failure patients irrespective of the ejection fraction based on new trial DELIVER conducted by AstraZeneca
Health-tech startups have the potential to revolutionize the healthcare sector by supporting innovations
This product would be manufactured at Lupin's Nagpur facility in India
The net profit in the June quarter was also lower than Rs 146.3 crore reported in the March quarter.
Good momentum in commercial CDMO business
Luforbec® 100/6 pMDI aims to provide comprehensive support to patients and healthcare professionals
KEYTRUDA plus concurrent chemoradiotherapy demonstrated statistically significant and clinically meaningful improvement in PFS versus concurrent chemoradiotherapy alone in these patients
Subscribe To Our Newsletter & Stay Updated
